SpinoS

Call Us

(+91422) 4352491

Opening hours

Mon - Sat : 09AM - 05PM

Email

info@spinoslifescience.com

Infrastructure

SpinoS Life Science and Research Private Ltd has an art of infrastructure to facilitate various aspects of Clinical research.

  • The main components of infrastructure at SpinoS are well equipped facilities, Equipments / Instruments , regulatory compliant software and hardware and secured networks ,with in-house capability to support every aspect of Clinical Research.
  • We do GCP / GLP-compliant clinical trial Chromotographic assay& ligand binding using .
  • We have more than 350 validated Bioanalytical methods & have handled around 130 molecules
  • In a very short span of 03 Years we have completed 196 BA/BE studies
  • Validated challenging Molecules like

Albendazole/ Calcium Dobesilate / Dabigatron Silodosin Glucronide /Imatinib / Crisotinib/ Saxagliptin / Pomalidomide /Dapagliflozin /Brexiprazole /Sofosbuvir and So Sulfasalazine and the metabolite Sulphaphyridine & 5Aminosalicylic Acid and Simvastatin acid, Posaconazole , Paroxetine , Bedaquiline , Aripiprazole / Imatinib / Lapatinib/ Nilotinib etc…

  • Total 44000 square feet air conditioned facility for BA/BE studies
  • 4 LC/MS-MS with high throughput & sensitivity connected with UPLCwith state-of-the-art detection techniques.
  • Well Designed 7 CPUs with an overall capacity of 100 beds to conduct mixed population studies at a same time.
  • NABL accredited pathology lab.
  • Round the clock power back up .
  • Round the clock Facility for management of emergency which includes:
    • AE monitoring and reporting, with fully equipped ICU
    • Round the clock medical surveillance
    • Adequate stores of emergency medications and equipment.
  • In-house Ambulance services.
  • Volunteer data base of around 33000.
  • OVIS software to identify cross participation
  • Full proof server connected ECG
  • Separate recreational area for Male and Female subjects.
  • Online Monitoring and recording temperature in all critical areas.